| Date Filed | Type | Description |
| 08/07/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 9.5% stake in Inozyme Pharma, Inc. |
| 08/03/2023 |
4
| Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 119,048 shares
@ $4.8, valued at
$571.4k
Bought 714,285 shares
@ $4.8, valued at
$3.4M
|
|
| 05/23/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 8.3% stake in Inozyme Pharma, Inc. |
| 04/04/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 7.4% stake in Inozyme Pharma, Inc. |
| 03/15/2023 |
SC 13G
| Pivotal bioVenture Partners Fund I, L.P. reports a 9.3% stake in Oculis Holding AG |
| 08/25/2022 |
SC 13G/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 4.9% stake in Akouos, Inc. |
| 04/28/2022 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 6.6% stake in Inozyme Pharma, Inc. |
| 04/20/2022 |
4
| Pivotal bioVenture Partners Fund I, L.P. (Director) has filed a Form 4 on Inozyme Pharma, Inc.|
Txns:
| Bought 1,070,000 shares
@ $3.69, valued at
$3.9M
|
|
| 02/14/2022 |
SC 13G/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 6.7% stake in Inozyme Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/13/2021 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 8.4% stake in Bolt Biotherapeutics, Inc. |
| 08/12/2021 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 7.3% stake in Rallybio Corporation |
| 02/17/2021 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 5.5% stake in Bolt Biotherapeutics, Inc. |
| 02/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/04/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/10/2020 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 5.5% stake in Akouos, Inc. |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/02/2018 |
4
| Pivotal bioVenture Partners Fund I, L.P. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Converted 359,267 shares
@ $0
Converted 458,425 shares
@ $0
Bought 337,724 shares
@ $15, valued at
$5.1M
Converted 7,446,904 options to buy
@ $0
Converted 9,502,249 options to buy
@ $0 |
|
| 09/25/2018 |
3
| Pivotal bioVenture Partners Fund I, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 03/29/2018 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 03/29/2017 |
D/A
| Form D/A - Notice of Exempt Offering of Securities [Amend] |